Clinical Labs Under ACA: Challenge And Opportunity

Law360, New York (January 16, 2014, 12:48 AM ET) -- Diagnostic clinical laboratory and pathology tests are the backbone of health care for patients, providing invaluable information regarding the presence or absence of disease, the progression of illness, and the effects of treatment. More recently, the scientific and technological advances in the development of genetic and genomic tests present even greater opportunities for practitioners to determine an individual’s predisposition toward disease or response to a drug regimen.

The accelerated movement toward personalized, evidence-based medicine, pushed forward by the demands of providers, payors and patients alike, underscores...
To view the full article, register now.